Sign in
4

Changes in Ownership

Summit Therapeutics Inc. Filed Acc 0001387131-22-012236

Chief Executive Officer acquired 9,346,434 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
DUGGAN ROBERT W Chief Executive Officer 2022-12-06 Other acquisition +9,346,434 171,879,226 D: show line 1 in the form
Loading xslF345X03/duggan-form4_120622.xml…